Archives

by in
Entry Author Date Location
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
FDA OKs First-in-Class Drug From Isis for Rare Cholesterol Disorder 01/29/13 San Diego
iRobot Sees Big Future in Remote Communications 01/23/13 Boston
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
San Diego Life Sciences Roundup: Illumina, Santarus, Accelrys, & More 01/18/13 San Diego
Sanford-Burnham’s CEO Sees Incredible Opportunity in Move to Roche 01/16/13 San Diego
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
San Diego Life Sciences Roundup: Trius, CoDa, Zacharon, & More 01/11/13 San Diego
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Got Cancer? Sorry, There’s No App for That 01/10/13 Seattle
After Clinical Trial Setback, San Diego’s MediciNova Sets New Course 01/08/13 San Diego
Biotech CEOs See Insurers as the New Boogeymen, Not FDA 01/07/13 National
My Report Card for JP Morgan Healthcare Conference Picks 01/07/13 National
SD Life Sciences Roundup: Organovo, Aethlon, & Deals, Deals, Deals 01/04/13 San Diego
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
FDA Approves J&J Drug for Multi-Drug Resistant Tuberculosis 12/31/12 New York
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
A Banner Year for New Drugs 12/26/12 Boston
NPS Wins First FDA Approval, for Short Bowel Syndrome Drug 12/21/12 New York
Ultragenyx, Led by BioMarin Vet, Snags $75M for Ultra-Rare Diseases 12/20/12 San Francisco
UW Spinoff PhysioSonics Gets FDA OK For Monitoring Brain Blood Flow 12/19/12 Seattle
Five Tips for Building a Successful Relationship with the FDA 12/19/12 San Diego
After Strikeout, San Diego’s MEI Pharma Looks to Rebuild Confidence 12/17/12 San Diego
FDA Approves Ariad Leukemia Drug Three Months Ahead of Schedule 12/14/12 Boston
Aastrom Names New Interim CEO, Mayleben To Remain Active in Fundraising 12/14/12 Detroit
San Diego Life Sciences Roundup: Acadia, Zogenix, Isis, & More 12/14/12 San Diego
Pernix Buyout Ends Generic Nightmare for Sleeping Pill Maker Somaxon 12/12/12 San Diego
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
Page 2 of 35 « previous page · next page »